3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid

3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is a lipid of Sterol Lipids (ST) class. 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is associated with abnormalities such as Cholestasis and Little's Disease. The involved functions are known as inhibitors, Signal Transduction, Phosphorylation, Cell Survival and Detergents. 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid often locates in Protoplasm. The related lipids are Promega.

Cross Reference

Introduction

To understand associated biological information of 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?

3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is suspected in Cholestasis, Little's Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Crohn Disease D003424 12 associated lipids
Cholelithiasis D002769 16 associated lipids
Blastomycosis D001759 5 associated lipids
Total 6

PubChem Associated disorders and diseases

What pathways are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid

Download all related citations
Per page 10 20 50 100 | Total 3280
Authors Title Published Journal PubMed Link
Borges MM et al. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil. 2017 Jan-Feb Rev. Soc. Bras. Med. Trop. pmid:28327804
Oliveira MME et al. Fungemia associated with Schizophyllum commune in Brazil. 2017 PLoS Negl Trop Dis pmid:28662024
Menotti J et al. A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. 2017 Toxicol. Appl. Pharmacol. pmid:28865757
Fraenza CC and Anoardo E Dynamical regimes of lipids in additivated liposomes with enhanced elasticity: A field-cycling NMR relaxometry approach. 2017 Biophys. Chem. pmid:28697447
Alvarez C et al. Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation. 2017 Pharm. Res. pmid:28205003
Rolón M et al. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections. 2017 Mol. Pharm. pmid:28198632
Grisin T et al. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model. 2017 Pharm. Res. pmid:28168390
Grisin T et al. Cyclodextrin-mediated self-associating chitosan micro-platelets act as a drug booster against Candida glabrata mucosal infection in immunocompetent mice. 2017 Int J Pharm pmid:28130196
Liu H et al. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin. 2017 Mater Sci Eng C Mater Biol Appl pmid:28415498
Khattab SN et al. Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives. 2017 Bioorg. Med. Chem. Lett. pmid:28087274
Lovero G et al. Invitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest. 2017 J. Med. Microbiol. pmid:27959780
Wang RY et al. Cryptococcosis in patients with hematological diseases: a 14-year retrospective clinical analysis in a Chinese tertiary hospital. 2017 BMC Infect. Dis. pmid:28673256
Le T et al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. 2017 N. Engl. J. Med. pmid:28614691
Kim JY et al. Selective effect of phosphatidylcholine on the lysis of adipocytes. 2017 PLoS ONE pmid:28463991
Shridharani SM Early Experience in 100 Consecutive Patients With Injection Adipocytolysis for Neck Contouring With ATX-101 (Deoxycholic Acid). 2017 Dermatol Surg pmid:28448317
Song Y et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. 2017 BMC Infect. Dis. pmid:28420334
Concha-Velasco F et al. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis. 2017 PLoS ONE pmid:28355252
Zhao C et al. Discovery and Synthesis of Amino Acids Modified Deoxycholic Acid Derivatives and in Vitro Antiproliferative Evaluation. 2017 Chem. Pharm. Bull. pmid:28090067
Duran MI et al. Synthesis of Five Known Brassinosteroid Analogs from Hyodeoxycholic Acid and Their Activities as Plant-Growth Regulators. 2017 Int J Mol Sci pmid:28282853
Miyamoto N et al. A two-component micelle with emergent pH responsiveness by mixing dilauroyl phosphocholine and deoxycholic acid and its delivery of proteins into the cytosol. 2017 Colloids Surf B Biointerfaces pmid:28347946
Hsu CY et al. Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting. 2017 Int J Nanomedicine pmid:29184410
Bhari N et al. Histoplasmosis mimicking non-Hodgkin lymphoma in a 40-year-old man with AIDS. 2017 Int J STD AIDS pmid:27535728
Kobayashi Y et al. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). 2017 Intern. Med. pmid:28381740
Chen L et al. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. 2017 Mater Sci Eng C Mater Biol Appl pmid:27770912
Abdel-Latif MM et al. Factors regulating nuclear factor-kappa B activation in esophageal cancer cells: Role of bile acids and acid. 2016 Jan-Mar J Cancer Res Ther pmid:27072265
Tang Y et al. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:27102560
Sun P et al. Influence of 5% dextrose volume on amphotericin B deoxycholate preparation. 2016 J. Pharm. Pharmacol. pmid:26992126
Xiong XH et al. Absorption mechanism of oxymatrine in cultured Madin-Darby canine kidney cell monolayers. 2016 Pharm Biol pmid:26983455
Smits MM et al. Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. 2016 Diabetes Obes Metab pmid:27451030
Djanic M et al. Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria. 2016 Eur Rev Med Pharmacol Sci pmid:26914133
Dossa AY et al. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26608185
Zheng H et al. A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset. 2016 Eur. J. Clin. Microbiol. Infect. Dis. pmid:26792138
Farhana L et al. Bile acid: a potential inducer of colon cancer stem cells. 2016 Stem Cell Res Ther pmid:27908290
Zia Q et al. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index. 2016 Curr. Pharm. Des. pmid:26648472
Serafim C et al. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B. 2016 Int J Pharm pmid:26617315
Zhang Y et al. [Clinical comparative analysis for pulmonary histoplasmosis and progressive disseminated histoplasmosis]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070050
El-Nabarawi MA et al. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. 2016 Drug Des Devel Ther pmid:28008227
Hwang SR et al. Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex. 2016 Int J Nanomedicine pmid:27621618
Herrera H et al. Structural Modifications of Deoxycholic Acid to Obtain Three Known Brassinosteroid Analogues and Full NMR Spectroscopic Characterization. 2016 Molecules pmid:27618889
Humphrey S et al. Sodium Deoxycholate for Submental Contouring. 2016 Skin Therapy Lett. pmid:27603325
Abeijon C et al. Novel Antigen Detection Assay to Monitor Therapeutic Efficacy of Visceral Leishmaniasis. 2016 Am. J. Trop. Med. Hyg. pmid:27481058
Meiring S et al. Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa. 2016 PLoS Negl Trop Dis pmid:27467556
Humphrey S et al. ATX-101 for reduction of submental fat: A phase III randomized controlled trial. 2016 J. Am. Acad. Dermatol. pmid:27430612
Barker JH et al. Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A. 2016 PLoS ONE pmid:27326857
Xie G et al. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. 2016 Int. J. Cancer pmid:27273788
Paredes K et al. Virulence and Experimental Treatment of Trichoderma longibrachiatum, a Fungus Refractory to Treatment. 2016 Antimicrob. Agents Chemother. pmid:27216056
Coelho AC et al. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome. 2016 PLoS Negl Trop Dis pmid:27144739
Nalwanga D and Henning L If It Looks Like a Duck, Swims Like a Duck, and Quacks Like a Duck--Does It Have to Be a Duck? 2016 PLoS Negl Trop Dis pmid:27124154
Shen C et al. Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2. 2016 Cell Cycle pmid:27096226
Centuori SM et al. Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells. 2016 Biochim. Biophys. Acta pmid:27086143
Merry M and Boulware DR Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis. 2016 Clin. Infect. Dis. pmid:27009249
Ridlon JM et al. Taurocholic acid metabolism by gut microbes and colon cancer. 2016 Gut Microbes pmid:27003186
Moore SM et al. Extraction, Enrichment, Solubilization, and Digestion Techniques for Membrane Proteomics. 2016 J. Proteome Res. pmid:26979493
Yasugi M et al. Transcriptional Profile during Deoxycholate-Induced Sporulation in a Clostridium perfringens Isolate Causing Foodborne Illness. 2016 Appl. Environ. Microbiol. pmid:26969700
Nascimento E et al. Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates. 2016 Am. J. Trop. Med. Hyg. pmid:26928832
Thapa S et al. Persistent Fever and Skin Lesions Due to Histoplasmosis in a Boy from Rural Nepal. 2016 Am. J. Trop. Med. Hyg. pmid:26843610
Stone NR et al. Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. 2016 Drugs pmid:26818726
Pardon NA et al. A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26797397
Fu Y et al. Decellularization of porcine skeletal muscle extracellular matrix for the formulation of a matrix hydrogel: a preliminary study. 2016 J. Cell. Mol. Med. pmid:26781342
Mahmoud RY et al. The Multivalent Adhesion Molecule SSO1327 plays a key role in Shigella sonnei pathogenesis. 2016 Mol. Microbiol. pmid:26481305
Kiggundu R et al. Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal Meningitis. 2016 J. Acquir. Immune Defic. Syndr. pmid:26334743
Adhikari K et al. Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation. 2016 AAPS PharmSciTech pmid:26349688
Surampalli G et al. Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery. 2016 Drug Deliv pmid:24937377
Rocheblave L et al. Deoxycholic acid derivatives as inhibitors of P-glycoprotein-mediated multidrug efflux. 2016 Steroids pmid:27697501
Fan J et al. Shear rheology and in-vitro release kinetic study of apigenin from lyotropic liquid crystal. 2016 Int J Pharm pmid:26657272
Mei L et al. Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug. 2016 ACS Appl Mater Interfaces pmid:27058058
Alvarez C et al. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B. 2016 Pharm. Res. pmid:27198671
Berger ML Soaping the NMDA receptor: Various types of detergents influence differently [(3)H]MK-801 binding to rat brain membranes. 2016 Biochim. Biophys. Acta pmid:26518518
Yan JK et al. Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin. 2015 Int. J. Biol. Macromol. pmid:25193095
Souza AC et al. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles. 2015 Eur J Med Chem pmid:25827397
Martinez Mdel C et al. Experimental protoporphyria: effect of bile acids on liver damage induced by griseofulvin. 2015 Biomed Res Int pmid:25945334
Saracut C et al. Secondary bile acids effects in colon pathology. Experimental mice study. 2015 Acta Cir Bras pmid:26465107
Botero Aguirre JP and Restrepo Hamid AM Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function. 2015 Cochrane Database Syst Rev pmid:26595825
Wade KC and Monk HM New antifungal and antiviral dosing. 2015 Clin Perinatol pmid:25678004
Chaturvedi K et al. Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles. 2015 Nanomedicine (Lond) pmid:26008194
Iatta R et al. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections. 2015 Med. Mycol. pmid:25631480
Falci DR et al. Hematological toxicities associated with amphotericin B formulations. 2015 Leuk. Lymphoma pmid:25629990
Wang CS et al. Bile acids cycle disruption in patients with nasopharyngeal carcinoma promotes the elevation of interleukin-10 secretion. 2015 Afr Health Sci pmid:26958021
Trifilio SM et al. Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection. 2015 Transpl Infect Dis pmid:25620386
Rodrigues PM et al. Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. 2015 Sci Rep pmid:26621219
Sousa T et al. Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties. 2015 J. Lipid Res. pmid:26351365
Bicanic T et al. Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis. 2015 Antimicrob. Agents Chemother. pmid:26349818
Rocha PN et al. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury. 2015 Antimicrob. Agents Chemother. pmid:26303800
Scheerlinck E et al. Minimizing technical variation during sample preparation prior to label-free quantitative mass spectrometry. 2015 Anal. Biochem. pmid:26302362
Kim DH and Larson AC Deoxycholate bile acid directed synthesis of branched Au nanostructures for near infrared photothermal ablation. 2015 Biomaterials pmid:25934288
Peng KW et al. Ethnic variability in the expression of hepatic drug transporters: absolute quantification by an optimized targeted quantitative proteomic approach. 2015 Drug Metab. Dispos. pmid:25926430
Barnes R et al. Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients. 2015 Clin Ther pmid:25891805
Falci DR et al. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study. 2015 Mycoses pmid:25590436
Jiang J et al. Mechanism of enhanced antiosteoporosis effect of circinal-icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate. 2015 Int J Nanomedicine pmid:25848257
Dayal D et al. Outcome of Rhino-Sinus Mucormycosis in Children with Type 1 Diabetes. 2015 Indian J Pediatr pmid:25589195
Botero-Calderon L et al. Advances in the treatment of invasive neonatal candidiasis. 2015 Expert Opin Pharmacother pmid:25842986
Wei WH et al. In vitro investigation of self-assembled nanoparticles based on hyaluronic acid-deoxycholic acid conjugates for controlled release doxorubicin: effect of degree of substitution of deoxycholic acid. 2015 Int J Mol Sci pmid:25837468
Zhang JW et al. Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury. 2015 World J. Gastroenterol. pmid:25834318
Miller AO et al. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention. 2015 Infect Dis (Lond) pmid:25539148
Esteves M et al. Interaction of Cytotoxic and Cytoprotective Bile Acids with Model Membranes: Influence of the Membrane Composition. 2015 Langmuir pmid:26218497
Lee JY et al. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. 2015 Eur J Pharm Biopharm pmid:26149228
Moreno-Rodríguez AC et al. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections. 2015 Int J Pharm pmid:26256151
Yang Y et al. Enhancing vitamin E bioaccessibility: factors impacting solubilization and hydrolysis of α-tocopherol acetate encapsulated in emulsion-based delivery systems. 2015 Food Funct pmid:25312787
Houdek MT et al. Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate. 2015 J Arthroplasty pmid:26162513
Kevric I et al. New World and Old World Leishmania Infections: A Practical Review. 2015 Dermatol Clin pmid:26143433